Skip to main content
Premium Trial:

Request an Annual Quote

Valigen to Apply Third Wave Agbio Technology to Genetically Modified Plants

NEW YORK, July 18 – Third Wave Agbio said Wednesday that Valigen has agreed to use its Invader SNP analysis platform to study genetic variations in plants.

As part of its research into developing agricultural products with improved traits, Valigen, headquartered in Paris-la-Defense, France, will use Third Wave Agbio’s technology to detect genetic changes in plants modified using Valigen’s Genoplasty technology. 

Financial details of the deal were not disclosed. 

The Genoplasty technology allows Valigen to introduce an oligonucleotide into a target cell, and use the cell’s mechanism for DNA repair to modify its genetic sequence according to the sequence of the oligonucleotide.

Third Wave Technologies, based in Madison, Wisc., is a significant stakeholder in Third Wave Agbio, also of Madison.  

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.